Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis
Rheumatoid arthritis (RA), a chronic inflammatory disease, is characterized by cartilage damage, bone tissue destruction, morphological changes in synovial fluids, and synovial joint inflammation. The inflamed synovial tissue has potential for passive and active targeting because of enhanced permeab...
Saved in:
Main Authors: | Jaber Emami (Author), Zahra Ansarypour (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted drug delivery of Methotrexate in situ gels for the treatment of Rheumatoid Arthritis
by: Madhugiri Prakash Venkatesh, et al.
Published: (2020) -
Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment
by: Hanmei Li, et al.
Published: (2023) -
Carbon Nanotubes-Potent Carriers for Targeted Drug Delivery in Rheumatoid Arthritis
by: Camilla Kofoed Andersen, et al.
Published: (2021) -
Bone-Targeted Delivery of Novokinin as an Alternative Treatment Option for Rheumatoid Arthritis
by: Arina Ranjit, et al.
Published: (2022) -
PROSPECT IN TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS WITH ADALIMUMAB
by: E.I. Alexeeva, et al.
Published: (2008)